BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DeKosky ST, Kochanek PM, Valadka AB, Clark RSB, Chou SH, Au AK, Horvat C, Jha RM, Mannix R, Wisniewski SR, Wintermark M, Rowell SE, Welch RD, Lewis L, House S, Tanzi RE, Smith DR, Vittor AY, Denslow ND, Davis MD, Glushakova OY, Hayes RL. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J Neurotrauma 2021;38:1-43. [PMID: 33115334 DOI: 10.1089/neu.2020.7332] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Ali Bodaghi, Nadia Fattahi, Ali Ramazani. Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon 2023:e13323. [ DOI: 10.1016/j.heliyon.2023.e13323] [Reference Citation Analysis]
2 Fang C, Ma Y. Peripheral Blood Genes Crosstalk between COVID-19 and Sepsis. IJMS 2023;24:2591. [DOI: 10.3390/ijms24032591] [Reference Citation Analysis]
3 Lai Y, Liu S, Manachevakul S, Lee T, Kuo C, Bello D. Biomarkers in long COVID-19: A systematic review. Front Med 2023;10. [DOI: 10.3389/fmed.2023.1085988] [Reference Citation Analysis]
4 Alqahtani MS, Abbas M, Alshahrani MY, Alabdullh K, Alqarni A, Alqahtani FF, Jambi LK, Alkhayat A. Effects of COVID-19 on Synaptic and Neuronal Degeneration. Brain Sci 2023;13. [PMID: 36672112 DOI: 10.3390/brainsci13010131] [Reference Citation Analysis]
5 Ayed M, Alsaffar Z, Bahzad Z, Buhamad Y, Abdulkareem A, AlQattan A, Embaireeg A, Kartam M, Alkandari H. Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age. Can J Infect Dis Med Microbiol 2023;2023:6140085. [PMID: 36632169 DOI: 10.1155/2023/6140085] [Reference Citation Analysis]
6 Lindstad MØ, Obstfelder AU, Sveen U, Stigen L. Effectiveness of the Perceive, Recall, Plan and Perform intervention for persons with brain injury in community-based rehabilitation: protocol for a single-case experimental design with multiple baselines. BMJ Open 2022;12:e060206. [PMID: 36198473 DOI: 10.1136/bmjopen-2021-060206] [Reference Citation Analysis]
7 Morales RT, Ko J. Future of Digital Assays to Resolve Clinical Heterogeneity of Single Extracellular Vesicles. ACS Nano 2022;16:11619-45. [PMID: 35904433 DOI: 10.1021/acsnano.2c04337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang L, Western D, Timsina J, Repaci C, Song WM, Norton J, Kohlfeld P, Budde J, Climer S, Butt OH, Jacobson D, Garvin M, Templeton AR, Campagna S, O'Halloran J, Presti R, Goss CW, Mudd PA, Ances BM, Zhang B, Sung YJ, Cruchaga C. Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer and coronary disease pathways. medRxiv 2022:2022. [PMID: 35923315 DOI: 10.1101/2022.07.25.22278025] [Reference Citation Analysis]
9 Ghaznavi H, Mohammadghasemipour Z, Shirvaliloo M, Momeni MK, Metanat M, Gorgani F, Abedipour F, Mohammadi M, Sartipi M, Khorashad ARS, Shahraki O, Ataee M, Sheervalilou R, Sargazi S. Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients. Inflammopharmacology 2022. [PMID: 35834150 DOI: 10.1007/s10787-022-01029-4] [Reference Citation Analysis]
10 Sodagar A, Javed R, Tahir H, Razak SIA, Shakir M, Naeem M, Yusof AHA, Sagadevan S, Hazafa A, Uddin J, Khan A, Al-harrasi A. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches. Biomolecules 2022;12:971. [DOI: 10.3390/biom12070971] [Reference Citation Analysis]
11 Al-qahtani SM, Shati AA, Alqahtani YA, Ali AS. Etiology, Clinical Phenotypes, Epidemiological Correlates, Laboratory Biomarkers and Diagnostic Challenges of Pediatric Viral Meningitis: Descriptive Review. Front Pediatr 2022;10:923125. [DOI: 10.3389/fped.2022.923125] [Reference Citation Analysis]
12 Tyagi M, Kapoor I, Mahajan C, Gupta N, Prabhakar H. Brain Biomarkers in Patients with COVID-19 and Neurological Manifestations: A Narrative Review. J Neuroanaesth Crit Care 2022;09:010-5. [DOI: 10.1055/s-0042-1744395] [Reference Citation Analysis]
13 Huang Y, Ling Q, Manyande A, Wu D, Xiang B. Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review. Front Neurosci 2022;16:855868. [DOI: 10.3389/fnins.2022.855868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ayed M, Alsaffar Z, Bahzad Z, Buhamad Y, Abdulkareem A, Alqattan A, Embaireeg A, Kartam M, Alkandari H. Coronavirus infection in neonates: Neurodevelopmental outcomes at 18 months of age.. [DOI: 10.1101/2022.04.15.22273460] [Reference Citation Analysis]
15 Babajani A, Moeinabadi-Bidgoli K, Niknejad F, Rismanchi H, Shafiee S, Shariatzadeh S, Jamshidi E, Farjoo MH, Niknejad H. Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation. Stem Cell Res Ther 2022;13:126. [PMID: 35337387 DOI: 10.1186/s13287-022-02794-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Nelson DW, Granberg T, Andersen P, Jokhadar E, Kåhlin J, Granström A, Hallinder H, Schening A, Thunborg C, Walles H, Hagman G, Shams-Latifi R, Yu J, Petersson S, Tzortzakakis A, Levak N, Aspö M, Piehl F, Zetterberg H, Kivipelto M, Eriksson LI. The Karolinska NeuroCOVID study protocol: Neurocognitive impairment, biomarkers and advanced imaging in critical care survivors. Acta Anaesthesiol Scand 2022. [PMID: 35332517 DOI: 10.1111/aas.14062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hua Y, Ma J, Li D, Wang R. DNA-Based Biosensors for the Biochemical Analysis: A Review. Biosensors (Basel) 2022;12:183. [PMID: 35323453 DOI: 10.3390/bios12030183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer's-like signaling in brains of COVID-19 patients. Alzheimers Dement 2022;18:955-65. [PMID: 35112786 DOI: 10.1002/alz.12558] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
19 Greuter L, Zweifel C, Guzman R, Soleman J. Perioperative Complications of Patients with SARS-CoV-2 Infection in Neurosurgery. J Clin Med 2022;11:657. [PMID: 35160106 DOI: 10.3390/jcm11030657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gutte S, Azim A, Patnaik R. Biomarkers in Hypoxic Brain Injury: Methods, Discoveries, and Applications. Biomarkers in Trauma, Injury and Critical Care 2022. [DOI: 10.1007/978-3-030-87302-8_26-1] [Reference Citation Analysis]
21 Cascella M, De Blasio E. Diagnostic Approaches to Acute Neuro-COVID. Features and Management of Acute and Chronic Neuro-Covid 2022. [DOI: 10.1007/978-3-030-86705-8_3] [Reference Citation Analysis]
22 Rakici S, Uslu G, Kucuktulu E. COVID-19 and radiotherapy: The ordeal faced by patients and staff during the pandemic in the 1st year. J Radiat Cancer Res 2022;0:0. [DOI: 10.4103/jrcr.jrcr_14_22] [Reference Citation Analysis]
23 Agoston DV. COVID-19 and Traumatic Brain Injury (TBI); What We Can Learn From the Viral Pandemic to Better Understand the Biology of TBI, Improve Diagnostics and Develop Evidence-Based Treatments. Front Neurol 2021;12. [DOI: 10.3389/fneur.2021.752937] [Reference Citation Analysis]
24 Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Kasozi KI, Zirintunda G, Aslam A, Allahyani M, Welburn SC, Batiha GE. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Front Immunol 2021;12:749291. [PMID: 34867978 DOI: 10.3389/fimmu.2021.749291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
25 Crisan R, Bacila CI, Neamtu B, Cristian AN, Topîrcean E, Popescu A, Morar S. Psychological Autopsy and Forensic Considerations in Completed Suicide of the SARS-CoV-2 Infected Patients. A Case Series and Literature Review. Applied Sciences 2021;11:11547. [DOI: 10.3390/app112311547] [Reference Citation Analysis]
26 Simon DW, Schober ME. Acute central and peripheral nervous system injury associated with coronavirus disease 2019: recognition and treatment strategies. Curr Opin Pediatr 2021;33:591-6. [PMID: 34670263 DOI: 10.1097/MOP.0000000000001070] [Reference Citation Analysis]
27 Fällmar D, Rostami E, Kumlien E, Ashton NJ, Jackmann S, Pavel R, Blennow K, Hultström M, Lipcsey M, Frithiof R, Westman G, Zetterberg H, Wikström J, Virhammar J. The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care. J Neuroradiol 2021:S0150-9861(21)00167-X. [PMID: 34800562 DOI: 10.1016/j.neurad.2021.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho H, Lu S, Goldberg SA, Hoh R, Tai V, Munter SE, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Martin JN, Kelly JD, Durstenfeld MS, Hsue PY, Hunt PW, Greene M, Chow FC, Hellmuth J, Henrich TJ, Glidden DV, Deeks SG. Plasma markers of neurologic injury and systemic inflammation in individuals with self-reported neurologic post-acute sequelae of SARS-CoV-2 infection (PASC).. [DOI: 10.1101/2021.11.02.21265778] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Maslov NE, Yuryeva NV, Khamtsova EI, Litvinova AA. Neuroimaging predictors of structural epilepsy in the COVID-19 catamnesis. Èpilepsiâ paroksizmalʹnye sostoâ 2021;13:274-285. [DOI: 10.17749/2077-8333/epi.par.con.2021.092] [Reference Citation Analysis]
30 Doyle MF. Central nervous system outcomes of COVID-19. Transl Res 2021:S1931-5244(21)00244-9. [PMID: 34601116 DOI: 10.1016/j.trsl.2021.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
31 Reisner A, Blackwell LS, Sayeed I, Myers HE, Wali B, Heilman S, Figueroa J, Lu A, Hussaini L, Anderson EJ, Shane AL, Rostad CA. Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study. Exp Biol Med (Maywood) 2021;:15353702211046835. [PMID: 34565198 DOI: 10.1177/15353702211046835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Barbosa-Silva MC, Lima MN, Battaglini D, Robba C, Pelosi P, Rocco PRM, Maron-Gutierrez T. Infectious disease-associated encephalopathies. Crit Care 2021;25:236. [PMID: 34229735 DOI: 10.1186/s13054-021-03659-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
33 Whitmore HAB, Kim LA. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19). Am J Pathol 2021:S0002-9440(21)00260-1. [PMID: 34126084 DOI: 10.1016/j.ajpath.2021.04.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
34 Laudanski K, Jihane H, Antalosky B, Ghani D, Phan U, Hernandez R, Okeke T, Wu J, Rader D, Susztak K. Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics. Front Immunol 2021;12:650465. [PMID: 34177897 DOI: 10.3389/fimmu.2021.650465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
35 Hassett CE, Frontera JA. Neurologic aspects of coronavirus disease of 2019 infection. Curr Opin Infect Dis 2021;34:217-27. [PMID: 33769966 DOI: 10.1097/QCO.0000000000000731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
36 Mainali S, Darsie ME. Neurologic and Neuroscientific Evidence in Aged COVID-19 Patients. Front Aging Neurosci 2021;13:648662. [PMID: 33833676 DOI: 10.3389/fnagi.2021.648662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Alexiou GA, Lianos GD, Alexiou ES, Voulgaris S. Biomarkers to safely discharge head trauma patients in the COVID-19 pandemic era. Biomark Med 2021;15:319-21. [PMID: 33666513 DOI: 10.2217/bmm-2021-0008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Lewis A, Frontera J, Placantonakis DG, Lighter J, Galetta S, Balcer L, Melmed KR. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci 2021;421:117316. [PMID: 33561753 DOI: 10.1016/j.jns.2021.117316] [Cited by in Crossref: 82] [Cited by in F6Publishing: 50] [Article Influence: 41.0] [Reference Citation Analysis]
39 Peluso L, Minini A, Taccone FS. How to monitor the brain in COVID-19 patients? Intensive Crit Care Nurs 2021;63:103011. [PMID: 33461861 DOI: 10.1016/j.iccn.2020.103011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Haidar MA, Jourdi H, Haj Hassan Z, Ashekyan O, Fardoun M, Wehbe Z, Maaliki D, Wehbe M, Mondello S, Abdelhady S, Shahjouei S, Bizri M, Mechref Y, Gold MS, Dbaibo G, Zaraket H, Eid AH, Kobeissy F. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. Neuroscientist 2021;:1073858420984106. [PMID: 33393420 DOI: 10.1177/1073858420984106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]